Blood thinners for the long-term treatment of blood clots in people with cancer

Of 15,785 citations, including 7602 unique citations, 16 RCTs fulfilled the eligibility criteria. These trials enrolled 5167 people with cancer and VTE. Low molecular weight heparins versus vitamin K antagonistsEight studies enrolling 2327 participants compared LMWHs with VKAs. Meta-analysis of five studies probably did not rule out a beneficial or […]

Donepezil for people with dementia due to Alzheimer's disease

Review question What effects (benefits or harms) does donepezil have on people with dementia due to Alzheimer’s disease? Background Alzheimer’s disease is the most common cause of dementia. As the disease progresses, people lose the ability to remember, communicate, think clearly and perform the activities of daily living. Their behaviour […]

Working Together for Value

June 20 by Centers for Medicare & Medicaid Services June 20, 2018  By Seema Verma, Administrator, Centers for Medicare & Medicaid Services Working Together for Value Over the past year, the Centers for Medicare & Medicaid Services (CMS) has engaged with the provider community in a discussion about regulatory burden […]

Advies experiment gesloten coffeeshopketen aangeboden aan ministers

Nieuwsbericht | 20-06-2018 | 18:15 Het rapport van de Adviescommissie Experiment gesloten coffeeshopketen is vandaag aangeboden aan minister Grapperhaus van Justitie en Veiligheid en minister Bruins van Medische Zorg en Sport. Het advies van de commissie onder leiding van voorzitter professor André Knottnerus is van belang voor de inrichting van […]

CDMO Minakem’s new Belgium HPAPI facility in final qualifications ahead of opening

Minakem, a CDMO subsidiary of Minafin, is in final qualifications to open its new closed-controlled environment high-containment production facility located in Belgium by late summer. The new facility will enhance Minakem’s ability to develop and manufacture HPAPI compounds, like antibody-drug conjugate toxins from small-scale development to full GMP batch releases, the […]

Madame Agnès Buzyn se rendra au foyer Robert Levillain à Paris

Madame Agnès BUZYN,Ministre des Solidarités et de la Santé, Se rendra au foyer Robert LEVILLAINMaison d’Enfants à Caractère Social Jeudi 21 juin 2018 à 10h0079 Rue de l’Eglise, 75015 Paris Déroulé 10h00 Arrivée au Foyer Robert Levillain et accueil par : Antoine ROUILLE-D’ORFEUIL, Directeur Général GROUPE SOS Flavie MEKHARCHI, Directrice […]

NZa-analyse bekostiging coördinatiepunten tijdelijk verblijf

Nieuwsbericht | 20-06-2018 | 14:09 Sinds 1 april 2018 is er een landelijk dekkend netwerk van coördinatiepunten voor eerstelijnsverblijf. Als vervolgstap wordt gekeken of de reeds opgezette coördinatiepunten verbreed kunnen worden naar alle zorgvormen met tijdelijk verblijf. De NZa werkte op verzoek van het ministerie van VWS opties uit om […]

Sommaren är högsäsong för magsjuka

Förra årets statistik från Folkhälsomyndigheten visar att mer än 14 000 personer blivit magsjuka av smittämnen som campylobacter, ehec, yersinia och salmonella. En stor del av dem som smittades av dessa sjukdomar insjuknade under sommarmånaderna, varav ungefär hälften smittades utomlands. Kända smittotillfällen på sommaren är till exempel felaktig hantering av […]

Fem nya ämnen blir narkotika

den 20 juni 2018 Regeringen har beslutat att fem nya ämnen blir narkotika från och med den 26 juni. Läkemedelsverkets föreskrifter om förteckningar över narkotika har uppdaterats i enlighet med ändringen. På förslag av Folkhälsomyndigheten har regeringen beslutat att flualprazolam, nitrazolam, 3-metoxieticyklidin (3-MeO-PCE), 3-hydroxifencyklidin (3-HO-PCP) och 3-fluoroetamfetamin (3-FEA) ska klassas […]

NHS could save £7 billion via new diagnostic techniques

Research commissioned by Innovate UK and the British In Vitro Diagnostics Association (BIVDA) has revealed that the NHS could save over £6.9 billion in five years through quick adoption of new diagnostic tests. These savings could help tackle the annual NHS shortfall that is expected to exceed £22 billion by […]

Kallyope and Novo Nordisk announce obesity and diabetes collaboration

Kallyope and Novo Nordisk have entered into a research collaboration and option agreement to discover novel peptide therapeutics for the treatment of obesity and diabetes. Under the joint plan, the two companies will collaborate on in vitro and in vivo studies to validate a number of product candidates. Following validation […]

“Extremely promising” blood test for autism impresses with 88% accuracy

A blood test designed to support the clinical determination of whether a child is on the autistic spectrum has been proven to be highly successful and could allow for earlier diagnosis, just one year after the original research was published. In the original study, the team examined data from 149 […]

Facebook unveils new feature to battle opioid crisis

Despite its highly-publicised transgressions recently, tech giant Facebook is looking to do the right thing by wading into the ongoing US opioid crisis with a new specialised feature on its social media platform. According to the company, any users looking to purchase illegal opioid products or seeking treatment for addiction […]